European equities traded in the US as American depositary receipts were falling on Friday morning, down 1.5% to 1,436.90 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech company Genfit (GNFT) and telecommunications company Ericsson (ERIC), which were rising 18% and 1% respectively.
The decliners from continental Europe were led by Danish pharmaceutical giant Novo Nordisk (NVO) and semiconductor manufacturing company STMicroelectronics (STM), which fell 5.9% and 4.4% respectively.
They were followed by semiconductor company ASML (ASML), which declined 3.8%.
From the UK and Ireland, the gainers were led by biotech companies Centessa Pharmaceuticals (CNTA) and Achilles Therapeutics (ACHL), which rose 3.9% and 2.8% respectively.
The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals (BDRX) and Autolus Therapeutics (AUTL), which lost 7.1% and 3.9% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。